NCT00006119View on ClinicalTrials.gov

Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1999

Primary Completion Date

December 31, 2004

Study Completion Date

January 31, 2008

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

hydroxyurea

Trial Locations (5)

33075

Hopital Saint Andre, Bordeaux

34298

Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle, Montpellier

35042

Centre Eugene Marquis, Rennes

37044

Centre Hospitalier Universitaire Bretonneau de Tours, Tours

69373

Centre Leon Berard, Lyon

All Listed Sponsors
lead

UNICANCER

OTHER

NCT00006119 - Hydroxyurea in Treating Patients With Recurrent and/or Unresectable Meningioma | Biotech Hunter | Biotech Hunter